IBDEI1H0 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23787,1,4,0)
 ;;=4^N94.810
 ;;^UTILITY(U,$J,358.3,23787,2)
 ;;=^336618
 ;;^UTILITY(U,$J,358.3,23788,0)
 ;;=N94.818^^82^1032^141
 ;;^UTILITY(U,$J,358.3,23788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23788,1,3,0)
 ;;=3^Vulvodynia,Other
 ;;^UTILITY(U,$J,358.3,23788,1,4,0)
 ;;=4^N94.818
 ;;^UTILITY(U,$J,358.3,23788,2)
 ;;=^5015923
 ;;^UTILITY(U,$J,358.3,23789,0)
 ;;=N94.819^^82^1032^142
 ;;^UTILITY(U,$J,358.3,23789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23789,1,3,0)
 ;;=3^Vulvodynia,Unspec
 ;;^UTILITY(U,$J,358.3,23789,1,4,0)
 ;;=4^N94.819
 ;;^UTILITY(U,$J,358.3,23789,2)
 ;;=^5015924
 ;;^UTILITY(U,$J,358.3,23790,0)
 ;;=N94.89^^82^1032^108
 ;;^UTILITY(U,$J,358.3,23790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23790,1,3,0)
 ;;=3^Pelvic Congestion Syndrome
 ;;^UTILITY(U,$J,358.3,23790,1,4,0)
 ;;=4^N94.89
 ;;^UTILITY(U,$J,358.3,23790,2)
 ;;=^5015925
 ;;^UTILITY(U,$J,358.3,23791,0)
 ;;=Z01.411^^82^1032^81
 ;;^UTILITY(U,$J,358.3,23791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23791,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,23791,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,23791,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,23792,0)
 ;;=Z90.722^^82^1032^12
 ;;^UTILITY(U,$J,358.3,23792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23792,1,3,0)
 ;;=3^Acq Absence,Ovaries,Bilateral
 ;;^UTILITY(U,$J,358.3,23792,1,4,0)
 ;;=4^Z90.722
 ;;^UTILITY(U,$J,358.3,23792,2)
 ;;=^5063595
 ;;^UTILITY(U,$J,358.3,23793,0)
 ;;=Z90.721^^82^1032^13
 ;;^UTILITY(U,$J,358.3,23793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23793,1,3,0)
 ;;=3^Acq Absence,Ovaries,Unilateral
 ;;^UTILITY(U,$J,358.3,23793,1,4,0)
 ;;=4^Z90.721
 ;;^UTILITY(U,$J,358.3,23793,2)
 ;;=^5063594
 ;;^UTILITY(U,$J,358.3,23794,0)
 ;;=Z90.79^^82^1032^11
 ;;^UTILITY(U,$J,358.3,23794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23794,1,3,0)
 ;;=3^Acq Absence,Oth Genital Organs-Fallop Tubes
 ;;^UTILITY(U,$J,358.3,23794,1,4,0)
 ;;=4^Z90.79
 ;;^UTILITY(U,$J,358.3,23794,2)
 ;;=^5063596
 ;;^UTILITY(U,$J,358.3,23795,0)
 ;;=D27.0^^82^1032^20
 ;;^UTILITY(U,$J,358.3,23795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23795,1,3,0)
 ;;=3^Benign Neop,Right Ovary
 ;;^UTILITY(U,$J,358.3,23795,1,4,0)
 ;;=4^D27.0
 ;;^UTILITY(U,$J,358.3,23795,2)
 ;;=^5002086
 ;;^UTILITY(U,$J,358.3,23796,0)
 ;;=D27.1^^82^1032^19
 ;;^UTILITY(U,$J,358.3,23796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23796,1,3,0)
 ;;=3^Benign Neop,Left Ovary
 ;;^UTILITY(U,$J,358.3,23796,1,4,0)
 ;;=4^D27.1
 ;;^UTILITY(U,$J,358.3,23796,2)
 ;;=^5002087
 ;;^UTILITY(U,$J,358.3,23797,0)
 ;;=D06.7^^82^1032^44
 ;;^UTILITY(U,$J,358.3,23797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23797,1,3,0)
 ;;=3^Carcinoma in Situ,Oth Parts of Cervix
 ;;^UTILITY(U,$J,358.3,23797,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,23797,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,23798,0)
 ;;=N84.1^^82^1032^48
 ;;^UTILITY(U,$J,358.3,23798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23798,1,3,0)
 ;;=3^Cervical Polyps
 ;;^UTILITY(U,$J,358.3,23798,1,4,0)
 ;;=4^N84.1
 ;;^UTILITY(U,$J,358.3,23798,2)
 ;;=^5015866
 ;;^UTILITY(U,$J,358.3,23799,0)
 ;;=N80.3^^82^1032^69
 ;;^UTILITY(U,$J,358.3,23799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23799,1,3,0)
 ;;=3^Endometriosis,Pelvic
 ;;^UTILITY(U,$J,358.3,23799,1,4,0)
 ;;=4^N80.3
 ;;^UTILITY(U,$J,358.3,23799,2)
 ;;=^270486
 ;;^UTILITY(U,$J,358.3,23800,0)
 ;;=D25.1^^82^1032^91
